After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Vir Biotechnology Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Vir Biotechnology Inc is $594.56M. A total of 1.78 million shares were traded on the day, compared to an average of 1.29M shares.
In the most recent transaction, SATO VICKI L sold 22,000 shares of VIR for 4.99 per share on Aug 01 ’25. After the transaction, the Director now owns 1,276,391 company shares. In a previous transaction on Jul 15 ’25, Eisner Mark sold 6,796 shares at 5.47 per share. VIR shares that EVP and Chief Medical Officer owns now total 108,204.
Among the insiders who sold shares, Eisner Mark disposed of 3,586 shares on Jul 17 ’25 at a per-share price of $5.47. This resulted in the EVP and Chief Medical Officer holding 104,618 shares of VIR after the transaction. In another insider transaction, MARK EISNER bought 3,586 shares at $5.41 per share on Jul 17 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, VIR has a high of $14.45 and a low of $4.25.
As of this writing, VIR has an earnings estimate of -$0.86 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.6 per share and a lower estimate of -$1.32. The company reported an EPS of -$1.56 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VIR’s latest balance sheet shows that the firm has $708.14M in Cash & Short Term Investments as of fiscal 2021. There were $137.49M in debt and $341.24M in liabilities at the time. Its Book Value Per Share was $6.82, while its Total Shareholder’s Equity was $1.43B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VIR is Buy with a score of 4.56.
